LEIDOS BIOMEDICAL RESEARCH, INC. recorded $8,076,175,752.22 in obligated federal awards across 1,656 actions during the last 10 years, with an average action value of $4,876,917.72. All reported obligations in this window were to the National Institutes of Health, with most spending in NAICS 541715 and 561210.
Federal Contractor
LEIDOS BIOMEDICAL RESEARCH, INC. Federal Contract Obligations (Last 10 Years)
Federal procurement summary for LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6, UEI HV8BH9BPG8Y9) covering obligations and award activity over the last 10 years.
Annual figures shown here include 2021 through 2025, and the NAICS breakdown reflects the largest obligation categories reported in the source data.
About LEIDOS BIOMEDICAL RESEARCH, INC. federal contract activity
LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6, UEI HV8BH9BPG8Y9) recorded 8.08 billion in obligated contract value across 1,656 awards over the last 10 years, for an average award value of 4.88 million. The obligation profile indicates a large, recurring federal research and support services footprint rather than a small number of one-time actions.
Agency mix and customer concentration
The award base is highly concentrated: the NATIONAL INSTITUTES OF HEALTH accounts for the full 8.08 billion in obligated value and all 1,656 awards in the provided top-agency view. This concentration suggests the vendor’s federal work is primarily tied to NIH-led research and biomedical support requirements.
Industry profile based on NAICS activity
The NAICS mix is dominated by 541715, Research and Development in the Physical, Engineering, and Life Sciences, with 6.11 billion across 1,045 awards. FACILITIES SUPPORT SERVICES (561210) is the second major category at 1.96 billion across 609 awards, while 334516 appears only marginally with 2 awards and no obligated value shown.
Annual contract trend over the analysis window
Annual obligations in the partial year sequence remain consistently high, ranging from 552.02 million in 2025 to a peak of 1.22 billion in 2023. Award counts also remained steady year to year, with 221 to 247 awards across 2021 through 2025, indicating sustained contract activity rather than volatile, episodic spending.
How to interpret this page
This summary is based on FPDS Query records for the last 10 years and uses the supplied totals, award counts, and category groupings for the vendor. Annual trend commentary is limited to the years provided in the input, and category interpretation reflects only the listed top agencies and NAICS codes without inferring unprovided contract details.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '3LYK6'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10
| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 7529 | NATIONAL INSTITUTES OF HEALTH | 8,076,175,752.22 | 8.08 billion | 1,656 |
Insight
Over the last 10 years, LEIDOS BIOMEDICAL RESEARCH, INC. has received 8.08 billion across 1,656 awards, for an average award value of about 4.88 million. Obligations are fully concentrated in the National Institutes of Health, indicating a single-agency dependence in the vendor’s federal portfolio. This level of concentration suggests that the vendor’s procurement activity is highly specialized and tied to NIH-funded requirements.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '3LYK6'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10
| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 6,112,976,334.98 | 6.11 billion | 1,045 |
| 561210 | FACILITIES SUPPORT SERVICES | 1,963,199,417.24 | 1.96 billion | 609 |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | 0.00 | 0.00 | 2 |
Insight
Over the last 10 years, LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6) received $8.08 billion across 1,656 awards, with obligations concentrated in two NAICS codes. NAICS 541715 accounted for $6.11 billion and 1,045 awards, or roughly three-quarters of total obligated value, indicating primary activity in research and development services. NAICS 561210 followed with $1.96 billion and 609 awards, showing a secondary but still substantial facilities support profile. NAICS 334516 appears only marginally, with 2 awards and no obligated value reported.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '3LYK6'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC
| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 552,024,126.52 | 552.02 million | 221 |
| 2024 | 868,786,229.92 | 868.79 million | 225 |
| 2023 | 1,216,293,757.91 | 1.22 billion | 242 |
| 2022 | 953,445,462.23 | 953.45 million | 247 |
| 2021 | 936,736,516.25 | 936.74 million | 227 |
| 2020 | 1,188,036,493.56 | 1.19 billion | 202 |
| 2019 | 657,834,553.44 | 657.83 million | 84 |
| 2018 | 784,890,570.21 | 784.89 million | 118 |
| 2017 | 880,296,108.18 | 880.30 million | 82 |
| 2016 | 37,831,934.00 | 37.83 million | 8 |
Insight
Over the last 10 years, LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6) received $8.08 billion across 1,656 awards, averaging $4.88 million per award. Obligations were highly concentrated in recent years, with annual funding consistently near or above $800 million from 2017 through 2024 and peaking at $1.22 billion in 2023; 2025 is lower year to date at $552.02 million across 221 awards. Activity was comparatively limited in 2016 at $37.83 million and 8 awards, indicating a sharp expansion in both volume and value over the period.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.